Study finds tecovirimat safe but ineffective in reducing mpox lesions or pain.
Vous n'êtes pas connecté
An interim analysis of the international clinical trial, the Study of Tecovirimat for Mpox (STOMP), revealed that the antiviral drug tecovirimat did not
Study finds tecovirimat safe but ineffective in reducing mpox lesions or pain.
December 10, 2024 -- The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to...
December 10, 2024 -- The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to...
FRIDAY, Dec. 20, 2024 -- The antiviral drug tecovirimat does not reduce the time to lesion resolution or pain among adults with mild-to-moderate clade...
FRIDAY, Dec. 20, 2024 -- The antiviral drug tecovirimat does not reduce the time to lesion resolution or pain among adults with mild-to-moderate clade...
Tryptamine reports positive interim analysis for its phase 2a clinical study of oral psilocybin formula TRP-8802 in patients with IBS. ...
The Office of the National Security Adviser (ONSA) has revealed that between October 2017 and December 2024, Nigeria secured 742 terror convictions,...
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for...
By Ryan McMaken Murray Rothbard is well known as an opponent of warfare perpetrated by states. This includes acts of war by states against other...
Saying he will be the one to decide—in consultation with anti-vaccine activist Robert F. Kennedy Jr.—which vaccines the federal government should...